Brief: Altamira Therapeutics, Univercells Group Partner On Nanoparticle-Delivered mRNA Vaccines
25/03/2024 13:56
March 25 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS ANNOUNCES COLLABORATION WITH
UNIVERCELLS
GROUP ON NANOPARTICLE-DELIVERED MRNA VACCINES
* ALTAMIRA THERAPEUTICS:UNDER DEAL, UNIVERCELLS TO TEST IN
VITRO &
IN VIVO PROPRIETARY MRNA VACCINE DELIVERED WITH CO'S SEMAPHORE
NANOPARTICLE PLATFORM
Source text for Eikon: ID:nGNX9t852x
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering